U.S. Markets close in 5 hrs 40 mins

  • S&P 500

    4,070.22
    +19.39 (+0.48%)
     

  • Dow 30

    33,005.08
    +146.05 (+0.44%)
     

  • Nasdaq

    12,084.07
    +70.60 (+0.59%)
     

  • Russell 2000

    1,786.55
    +18.16 (+1.03%)
     

  • Crude Oil

    75.24
    +0.87 (+1.17%)
     

  • Gold

    1,997.10
    -0.60 (-0.03%)
     

  • Silver

    24.19
    +0.20 (+0.84%)
     

  • EUR/USD

    1.0894
    -0.0014 (-0.1307%)
     

  • 10-Yr Bond

    3.5190
    -0.0320 (-0.90%)
     

  • Vix

    18.84
    -0.18 (-0.95%)
     

  • GBP/USD

    1.2392
    +0.0002 (+0.0124%)
     

  • USD/JPY

    132.8810
    +0.1920 (+0.1447%)
     

  • BTC-USD

    28,381.94
    +33.63 (+0.12%)
     

  • CMC Crypto 200

    621.74
    +7.53 (+1.23%)
     

  • FTSE 100

    7,639.58
    +19.15 (+0.25%)
     

  • Nikkei 225

    28,041.48
    +258.55 (+0.93%)
     

Cidara's Lead Antifungal Candidate Goes Under Priority FDA Review

Vandana Singh
·1 min read

  • The FDA accepted Cidara Therapeutics Inc's (NASDAQ: CDTX) marketing application seeking approval for rezafungin for candidemia and invasive candidiasis.

  • Under the priority review designation, the FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of March 22, 2023. The agency currently plans to hold an advisory committee meeting to discuss the application.

  • Related: With FDA Submission, Cidara Therapeutics Inks US Pact For Bloodstream Infection Candidate.

  • Rezafungin is a novel, once-weekly echinocandin antifungal being developed for the treatment of candidemia and invasive candidiasis, as well as for the prophylaxis of invasive fungal infections in patients undergoing allogeneic blood and marrow transplant.

  • The submission was supported by positive data from the global ReSTORE Phase 3 and STRIVE Phase 2 clinical trials.

  • Rezafungin dosed once weekly demonstrated statistical non-inferiority versus caspofungin, the current standard of care, dosed once daily.

  • Cidara retains the rights to rezafungin in Japan and has licensed the commercial rights to Melinta Therapeutics in the U.S. and Mundipharma Medical in all other geographies.

  • Price Action: CDTX shares are down 1.04% at $0.76 on the last check Wednesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • One of the world’s richest men knows why Silicon Valley Bank really failed: ‘People on iPhones’

    Stephen Schwartzman, worth $42 billion and at the head of a firm managing almost $1 trillion, says social media is what doomed the bank.

  • Dow Jones Rises 150 Points After Cool Inflation Data; 6 Stocks To Buy And Watch

    The Dow Jones rose Friday after key inflation data, with the release of the PCE price index, the Fed's preferred measure of inflation.

  • Procrastinators, Rejoice: The 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years

    With a yield of 9.62%, the recently expired Series I bond was understandably popular. With interest rates rising, bond funds are down this year and banks continue to offer miserly rates on deposit accounts. So it's no wonder that a … Continue reading → The post It Pays to Procrastinate: The New 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years appeared first on SmartAsset Blog.

  • Here’s What Retirement Looks Like in America in Six Charts

    Americans spend decades saving for retirement, never quite sure how much is enough or what sort of life that money will ultimately buy. To benchmark your retirement plans—including your savings and spending and how you spend your time—one place to start is by looking at how your numbers stack up against Americans overall. The biggest source of retirement income for many Americans is the nest egg built up during their careers.

  • DWAC Stock Jumps After Donald Trump Indictment

    Digital World Acquisition Corp. stock, the special purpose acquisition company aiming to take former President Donald Trump's tech and social-media platform public, soared Friday after a grand jury voted Thursday to indict Trump. The grand jury voted to indict Trump Thursday after hearing evidence the former president allegedly paid hush-money to a porn star during the 2016 election. Trump is now expected to come to New York to face the charges.

  • Baby Boomers, You Need This Much Money to Retire Comfortably

    The Baby Boomer generation is reaching retirement age in record numbers. With more Boomers retiring on a daily basis, it helps to understand how prepared they are to leave their jobs for good. In this article, we’ll discuss the average … Continue reading → The post Average Retirement Savings for Baby Boomers appeared first on SmartAsset Blog.

  • Warren Buffett and Morgan Stanley Have One Thing in Common: They Both Like These 2 Stocks

    Investors looking for alpha in an uncertain market environment could do worse than following in the footsteps of legendary stock pickers and probably none can match Warren Buffet’s reputation. Not for nothing the “Oracle of Omaha” is considered one of the all-time greats and for nearly 60 years, between 1965 and 2022, his Berkshire Hathaway firm’s returns have doubled those of the S&P 500. So, it’s definitely worth nosing through Buffett’s portfolio to see which stocks he currently holds. And wh

  • China to examine U.S. chipmaker Micron's products for cybersecurity risks

    China's cyberspace regulator will conduct a cybersecurity review of products sold in the country by U.S. memory chip manufacturer Micron Technology, the regulator said on Friday. The move is aimed at protecting the security of the supply chain for critical information infrastructure, prevent hidden risks and safeguard national security, the Cyberspace Administration of China said in a brief statement. It gave no other details, including which Micron products it was reviewing.

  • Japan's Toyota hands St Petersburg plant over to Russian state

    MOSCOW (Reuters) -Russia and Toyota said on Friday that the Japanese carmaker's factory in St Petersburg had been handed over to state entity NAMI, with Moscow snapping up more assets from global automakers leaving Russia over the conflict in Ukraine. "Toyota's production site in St Petersburg has... been transferred to the state," Russia's Ministry of Industry and Trade said in a statement. The company said in September it had decided to stop vehicle production in Russia due to the interruption in supplies of key materials and parts.

  • Financial world legend sounds alarm over 'biggest bank that's going down'

    Rich Day Company co-founder Robert Kiyosaki dissects why he foresees the Bank of Japan collapsing and the potential implications it could have on the global economy.

  • Can I Retire at 65 with $2.5 Million?

    For most people, it will be little or no problem to retire at age 65 if they have $2.5 million in savings. This amount of capital invested prudently is likely to provide sufficient income for a lifestyle comfortable enough to … Continue reading → The post Is $2.5 Million Enough to Retire at 65? appeared first on SmartAsset Blog.

  • Palantir Technologies Inc. (PLTR) Stock Sinks As Market Gains: What You Should Know

    Palantir Technologies Inc. (PLTR) closed the most recent trading day at $8.15, moving -0.85% from the previous trading session.

  • Y-mAbs Therapeutics, Inc. (YMAB) Surpasses Q4 Earnings and Revenue Estimates

    Y-mAbs Therapeutics, Inc. (YMAB) delivered earnings and revenue surprises of 106.82% and 50.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Devon Energy (DVN) Is Considered a Good Investment by Brokers: Is That True?

    According to the average brokerage recommendation (ABR), one should invest in Devon Energy (DVN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

  • Three Stocks Turn $10,000 To $25,265 In Just 3 Months

    Investors enjoyed a small S&P 500 rally in March. But there were much more lucrative places to put money in the month.

  • Stocks moving in after-hours: Nikola, Canoo, Virgin Orbit, Rumble

    Here are some of today's after-hours movers.

  • This Citigroup Preferred Yields 10%. Is It Too Good to Be True?

    A Citigroup preferred stock yields about 10%, an unusually good deal. Bank regulations passed in the wake of the financial crisis disallowed trust preferred as a component of Tier 1 bank capital but grandfathered the Citigroup issue. This gives Citigroup an incentive to keep the preferred outstanding.

  • A $200,000 Annuity Will Pay Out This Much a Month

    An annuity can be an appealing option to build your retirement nest egg. Adding guaranteed retirement income to your retirement can give you financial stability. But the exact amount that you'll get from an annuity each month will vary. Let's … Continue reading → The post How Much Does a $200,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

  • Pan American Silver (PAAS) Yamana Deal Clears Final Hurdle

    Pan American Silver's (PAAS) acquisition of Yamana Gold is expected to double its gold production and boost its silver production by 50%.

  • Jared Kushner's PE firm was backed by Emirates, Qatar - NYT

    The Emiratis invested more than $200 million with Kushner's Affinity Partners, while a Qatari entity also put in a similar sum, the newspaper said, citing people with knowledge of the transactions. Kushner, who was also a top adviser to Trump, formed the Miami-based Affinity Partners in 2021, Reuters had reported.